Notably, a 2020 clinical trial involving patients with nonalcoholic steatohepatitis (NASH) revealed a 15% incidence of tumors (benign, malignant, or unspecified) (35/239) among those administered semaglutide, compared to 8% (6/80) in the control group [108]
If Semaglutide is appropriate, well refer you to Care Validate for prescription and medication management
Well-rounded care: Whereas some telehealth providers just write the prescription for a weight-loss medication, Ro offers a complete weight-management program with access to diagnostic testing, a connected smart scale to track your progress, coaching from nurses and regular check-ins to discuss dosage adjustments and side effect management
On top of that, rising healthcare spending , and reimbursement frameworks that are more favorable, both help expand demand